FDA recalls Lidocaine-Prilocaine topical anesthetic cream for temperature abuse
McKesson Medical-Surgical is recalling Lidocaine and Prilocaine Cream due to cGMP deviations involving temperature abuse during distribution. The recall affects 23 tubes distributed nationwide.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard is a cGMP deviation related to temperature abuse during distribution—a precautionary manufacturing issue without evidence of actual product failure or patient harm.
Plain-English summary
McKesson Medical-Surgical Inc. is recalling Lidocaine and Prilocaine Cream, 2.5%/2.5%, in 5-gram tubes (NDC 0168-0357-56) distributed nationwide. The recall involves 23 tubes that were distributed in the United States.
The reason for the recall is a cGMP (current Good Manufacturing Practice) deviation related to temperature abuse during storage and distribution of the product. The specific nature of the risk posed by this temperature exposure is not detailed in the available recall information.
McKesson was unable to identify the specific lot numbers for individual consignees. Customers were notified individually with the dates when product was distributed to them and the dates when impacted product may have been shipped.
The recalled product
- Product
- LIDOCAINE AND PRILOCAINE (LIDOCAINE AND PRILOCAINE)
- Brand
- LIDOCAINE AND PRILOCAINE
- Manufacturer
- Mckesson Medical-Surgical Inc. Corporate Office
- Category
- Drug — Topical Anesthetic
- Affected units
- 23
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
UPCs (1)
- 0301680357300
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 130 recalled by Mckesson Medical-Surgical Inc. Corporate Office under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 130 products in this recall →Related recalls
Same manufacturer · Mckesson Medical-Surgical Inc. Corporate Office
See all →- ModerateStrep A test kits recalled after shipment to unlicensed purchasing customers
FDA (Devices) · 2025-08-27
- ModerateProlia prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateEvenity prefilled syringes recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateBenlysta vials recalled after potential temperature excursions during transit delays
FDA (Drugs) · 2025-07-30
- ModerateAbbott Diagnostics ARC Carbon Dioxide Calibrator Cold Chain Storage Issue
FDA (Devices) · 2025-06-04
Same hazard · temperature abuse
See all →- SevereKayem Foods Recalls Ready-to-Eat Meat and Poultry Due to Temperature Abuse
USDA FSIS · 2026-10-17
- ModerateZoladex Goserelin Implant Recalled Due to Temperature Abuse
FDA (Drugs) · 2026-10-07
- ModerateGemcitabine Injection Recalled Due to Temperature Storage Abuse
FDA (Drugs) · 2026-07-08
- ModerateChristopher Ranch peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
- ModerateGarland Fresh peeled garlic recalled over Clostridium botulinum contamination risk
FDA (Food) · 2026-05-13
Similar recalls
- HighFDA Recalls Lidocaine Prilocaine Cream Due to Manufacturing Compliance Issue
FDA (Drugs) · 2022-05-11
- HighFDA Recalls Lidocaine-Prilocaine Topical Cream for Manufacturing Practice Violations
FDA (Drugs) · 2022-05-04
- ModerateLidocaine-Prilocaine Cream Recalled Due to Incomplete Stability Studies
FDA (Drugs) · 2023-06-07
- HighProparacaine Hydrochloride Eye Drops Recalled Due to Temperature Exposure
FDA (Drugs) · 2024-10-02
- ModerateLidocaine Cream Products Recalled for Improper Storage Conditions at Family Dollar
FDA (Drugs) · 2022-08-31
- SevereAkorn Recalls Lidocaine and Prilocaine Cream Due to Impurity
FDA (Drugs) · 2018-08-15